Hoppa till innehåll
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Språk
Alla fält
Titel
Upphovsman
Ämne
Signum
ISBN/ISSN
Tagg
Sök
Avancerad
The novel ATR inhibitor VE-821...
Hänvisa
Textmeddelande
Skicka per e-post
Skriv ut
Exportera posten
Exportera till: RefWorks
Exportera till: EndNoteWeb
Exportera till: EndNote
Permanent länk
The novel ATR inhibitor VE-821 selectively sensitizes pancreatic cancer cells to radiation and chemotherapy
Bibliografiska uppgifter
Huvudupphovsmän:
Fokas, E
,
Prevo, R
,
Reaper, P
,
Charlton, P
,
Pollard, J
,
Mckenna, W
,
Muschel, R
,
Brunner, T
Materialtyp:
Conference item
Publicerad:
2012
Beståndsuppgifter
Beskrivning
Liknande verk
Katalogiseringsuppgifter
Beskrivning
Sammanfattning:
Liknande verk
The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy.
av: Prevo, R, et al.
Publicerad: (2012)
ATR targeting by the novel inhibitor VE-822 selectively sensitizes pancreatic cancer cells and tumors to radiation and chemoradiation
av: Fokas, E, et al.
Publicerad: (2013)
Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation.
av: Fokas, E, et al.
Publicerad: (2012)
Targeting ATR in DNA damage response and cancer therapeutics.
av: Fokas, E, et al.
Publicerad: (2014)
Targeting ATR in DNA damage response and cancer therapeutics
av: Fokas, E, et al.
Publicerad: (2014)